• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺高危病变:同步诊断工具及管理建议

High-risk lesions of the breast: concurrent diagnostic tools and management recommendations.

作者信息

Catanzariti Francesca, Avendano Daly, Cicero Giuseppe, Garza-Montemayor Margarita, Sofia Carmelo, Venanzi Rullo Emmanuele, Ascenti Giorgio, Pinker-Domenig Katja, Marino Maria Adele

机构信息

Department of Biomedical Sciences and Morphologic and Functional Imaging, University of Messina, Messina, Italy.

Department of Breast Imaging, Breast Cancer Center TecSalud, ITESM Monterrey, Nuevo Leon, Mexico.

出版信息

Insights Imaging. 2021 May 26;12(1):63. doi: 10.1186/s13244-021-01005-6.

DOI:10.1186/s13244-021-01005-6
PMID:34037876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8155169/
Abstract

Breast lesions with uncertain malignant behavior, also known as high-risk or B3 lesions, are composed of a variety of pathologies with differing risks of associated malignancy. While open excision was previously preferred to manage all high-risk lesions, tailored management has been increasingly favored to reduce overtreatment and spare patients from unnecessary anxiety or high healthcare costs associated with surgical excision. The purpose of this work is to provide the reader with an accurate overview focused on the main high-risk lesions of the breast: atypical intraductal epithelial proliferation (atypical ductal hyperplasia), lobular neoplasia (including the subcategories lobular carcinoma in situ and atypical lobular hyperplasia), flat epithelial atypia, radial scar and papillary lesions, and phyllodes tumor. Beyond merely presenting the radiological aspects of these lesions and the recent literature, information about their potential upgrade rates is discussed in order to provide a useful guide for appropriate clinical management while avoiding the risks of unnecessary surgical intervention (overtreatment).

摘要

具有不确定恶性行为的乳腺病变,也称为高危或B3病变,由多种具有不同相关恶性风险的病理类型组成。虽然以前首选开放切除来处理所有高危病变,但为了减少过度治疗并使患者免受与手术切除相关的不必要焦虑或高昂医疗费用,针对性管理越来越受到青睐。这项工作的目的是为读者提供一个准确的概述,重点关注乳腺的主要高危病变:非典型导管上皮增生(非典型导管增生)、小叶肿瘤(包括小叶原位癌和非典型小叶增生亚类)、扁平上皮异型增生、放射状瘢痕和乳头状病变,以及叶状肿瘤。除了仅仅呈现这些病变的放射学特征和近期文献外,还讨论了它们的潜在升级率信息,以便为适当的临床管理提供有用的指导,同时避免不必要手术干预(过度治疗)的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/299d7077b36c/13244_2021_1005_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/969d26427da0/13244_2021_1005_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/b6cf40bfabf7/13244_2021_1005_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/e6a9ec980c30/13244_2021_1005_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/50bc0f21fb93/13244_2021_1005_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/ddb63d539ca2/13244_2021_1005_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/a8949d00d10c/13244_2021_1005_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/bb581176abdf/13244_2021_1005_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/299d7077b36c/13244_2021_1005_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/969d26427da0/13244_2021_1005_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/b6cf40bfabf7/13244_2021_1005_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/e6a9ec980c30/13244_2021_1005_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/50bc0f21fb93/13244_2021_1005_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/ddb63d539ca2/13244_2021_1005_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/a8949d00d10c/13244_2021_1005_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/bb581176abdf/13244_2021_1005_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd90/8155169/299d7077b36c/13244_2021_1005_Fig8_HTML.jpg

相似文献

1
High-risk lesions of the breast: concurrent diagnostic tools and management recommendations.乳腺高危病变:同步诊断工具及管理建议
Insights Imaging. 2021 May 26;12(1):63. doi: 10.1186/s13244-021-01005-6.
2
B3 lesion upgrade rates in a tertiary Australian breast centre: a 8-year experience (2012-2019).澳大利亚一家三级乳腺中心的B3病变升级率:八年经验(2012 - 2019年)
ANZ J Surg. 2020 Dec;90(12):2521-2526. doi: 10.1111/ans.16315. Epub 2020 Sep 23.
3
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?在真空辅助活检 (VAB) 诊断为不确定恶性潜能 (B3) 的乳腺病变中,恶性的阳性预测值:是否仍建议手术切除?
Eur Radiol. 2021 Feb;31(2):920-927. doi: 10.1007/s00330-020-07161-5. Epub 2020 Aug 20.
4
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.欧洲乳腺不确定恶性潜能病变(B3 病变)诊治和随访指南(EUSOMA、EUSOBI、ESP(BWG)和 ESSO 联合制定)。
Eur J Surg Oncol. 2024 Jan;50(1):107292. doi: 10.1016/j.ejso.2023.107292. Epub 2023 Nov 27.
5
Assessment and management of B3 breast lesions with atypia: a focused review.B3 型乳腺病变伴不典型性评估与管理:重点综述。
Climacteric. 2020 Feb;23(1):17-23. doi: 10.1080/13697137.2019.1660637. Epub 2019 Sep 30.
6
Role of vacuum assisted excision in minimising overtreatment of ductal atypias.真空辅助切除在减少导管非典型增生过度治疗中的作用。
Eur J Radiol. 2020 Oct;131:109258. doi: 10.1016/j.ejrad.2020.109258. Epub 2020 Sep 1.
7
High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up.MRI引导下真空辅助乳腺活检诊断出的高危病变:影像学特征、手术切除结果或影像学随访
Breast Cancer. 2020 May;27(3):405-414. doi: 10.1007/s12282-019-01032-8. Epub 2019 Dec 14.
8
Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study.乳腺核心活检中诊断的伴有非典型上皮增生的放射状瘢痕/复杂硬化性病变的转归:一项基于英国的多中心研究结果。
J Clin Pathol. 2019 Dec;72(12):800-804. doi: 10.1136/jclinpath-2019-205764. Epub 2019 Jul 26.
9
Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.粗针活检确定的“恶性潜能不确定”和“怀疑恶性”乳腺病变的预测价值
Ann Surg Oncol. 2007 Feb;14(2):704-11. doi: 10.1245/s10434-006-9212-8. Epub 2006 Dec 7.
10
Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.乳腺 X 线筛查异常中经乳腺针芯活检诊断为不确定恶性潜能病变(B3)的特征和转归。
Int J Cancer. 2011 Sep 15;129(6):1417-24. doi: 10.1002/ijc.25801. Epub 2011 Feb 11.

引用本文的文献

1
A review of papillary breast carcinoma in women attending a breast imaging centre in Johannesburg.对约翰内斯堡一家乳腺影像中心的女性乳头状乳腺癌的综述。
SA J Radiol. 2025 May 2;29(1):3092. doi: 10.4102/sajr.v29i1.3092. eCollection 2025.
2
Influence of Complete Lesion Removal During Vacuum-Assisted Breast Biopsy on the Upgrade Rate of B3 Lesions Presenting as Microcalcifications.真空辅助乳腺活检时完全切除病变对以微钙化形式出现的B3级病变升级率的影响。
J Clin Med. 2025 Feb 24;14(5):1513. doi: 10.3390/jcm14051513.
3
Malignant upgrade in lesions of uncertain malignant potential in the breast (B3 lesions) - is open excision always necessary?

本文引用的文献

1
A risk stratification algorithm for lesions of uncertain malignant potential diagnosed by vacuum-assisted breast biopsy (VABB) of mammographic microcalcifications.一种用于真空辅助乳腺活检 (VABB) 诊断的乳腺微钙化不确定恶性潜能病变的风险分层算法。
Eur J Radiol. 2021 Feb;135:109479. doi: 10.1016/j.ejrad.2020.109479. Epub 2020 Dec 14.
2
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?在真空辅助活检 (VAB) 诊断为不确定恶性潜能 (B3) 的乳腺病变中,恶性的阳性预测值:是否仍建议手术切除?
Eur Radiol. 2021 Feb;31(2):920-927. doi: 10.1007/s00330-020-07161-5. Epub 2020 Aug 20.
3
乳腺恶性潜能不确定病变(B3 病变)的恶性进展——总是需要进行开放性切除吗?
Breast Cancer Res Treat. 2025 May;211(1):173-183. doi: 10.1007/s10549-025-07632-7. Epub 2025 Feb 17.
4
Navigating the Uncertainty of B3 Breast Lesions: Diagnostic Challenges and Evolving Management Strategies.应对B3级乳腺病变的不确定性:诊断挑战与不断发展的管理策略
J Pers Med. 2025 Jan 18;15(1):36. doi: 10.3390/jpm15010036.
5
Assessing Malignant Risk in B3 Breast Lesions: Clinical Insights and Implications.评估B3级乳腺病变的恶性风险:临床见解与启示
J Clin Med. 2024 Dec 26;14(1):70. doi: 10.3390/jcm14010070.
6
Contrast-Enhanced Mammography: A Literature Review of Clinical Uses for Cancer Diagnosis and Surgical Oncology.对比增强乳腺钼靶摄影:癌症诊断和外科肿瘤学临床应用的文献综述
Cancers (Basel). 2024 Dec 12;16(24):4143. doi: 10.3390/cancers16244143.
7
Assessment of pediatric breast ultrasound less is more: a practical imaging approach.小儿乳腺超声评估:少即是多——一种实用的成像方法
Acta Radiol. 2024 Dec;65(12):1465-1472. doi: 10.1177/02841851241287924. Epub 2024 Oct 15.
8
Discrimination Between Benign and Malignant Lesions With Restriction Spectrum Imaging MRI in an Enriched Breast Cancer Screening Cohort.在一个富集的乳腺癌筛查队列中,利用磁共振弹性成像鉴别乳腺良恶性病变。
J Magn Reson Imaging. 2025 Apr;61(4):1876-1887. doi: 10.1002/jmri.29599. Epub 2024 Sep 18.
9
Invasive papillary carcinoma of the breast: A case report.乳腺浸润性乳头状癌:一例报告。
Oncol Lett. 2024 May 2;28(1):300. doi: 10.3892/ol.2024.14433. eCollection 2024 Jul.
10
Invasive papillary carcinoma of the breast.乳腺浸润性乳头状癌
Front Oncol. 2024 Mar 27;14:1374091. doi: 10.3389/fonc.2024.1374091. eCollection 2024.
Radial scars and complex sclerosing lesions on core needle biopsy of the breast: upgrade rates and long-term outcomes.
乳腺芯针活检中的放射状瘢痕和复杂硬化性病变:升级率和长期结果。
Breast Cancer Res Treat. 2020 Oct;183(3):677-682. doi: 10.1007/s10549-020-05806-z. Epub 2020 Jul 21.
4
External Validation of a Risk Stratification Score for B3 Breast Lesions Detected at Ultrasound Core Needle Biopsy.超声引导下粗针穿刺活检发现的B3级乳腺病变风险分层评分的外部验证
Diagnostics (Basel). 2020 Mar 26;10(4):181. doi: 10.3390/diagnostics10040181.
5
Practical approach to diagnosis of bland-looking spindle cell lesions of the breast.乳腺外观平淡的梭形细胞病变的实用诊断方法
Pathologica. 2019 Dec;111(4):344-360. doi: 10.32074/1591-951X-31-19.
6
Atypical Ductal Hyperplasia and Lobular Neoplasia: Update and Easing of Guidelines.非典型导管增生和小叶肿瘤:指南更新和简化。
AJR Am J Roentgenol. 2020 Feb;214(2):265-275. doi: 10.2214/AJR.19.21991. Epub 2019 Dec 11.
7
Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study.乳腺核心针活检诊断的经典小叶肿瘤的结局:一项回顾性多中心研究。
Virchows Arch. 2020 Feb;476(2):209-217. doi: 10.1007/s00428-019-02685-8. Epub 2019 Nov 27.
8
Flat epithelial atypia: are we being too aggressive?平坦上皮不典型增生:我们是否过于激进?
Breast Cancer Res Treat. 2020 Jan;179(2):511-517. doi: 10.1007/s10549-019-05481-9. Epub 2019 Nov 7.
9
Management of Breast Atypical Ductal Hyperplasia: Now and the Future.乳腺非典型导管增生的管理:现状与未来
Radiology. 2020 Jan;294(1):87-88. doi: 10.1148/radiol.2019192192. Epub 2019 Oct 29.
10
Upgrade Rate of Percutaneously Diagnosed Pure Atypical Ductal Hyperplasia: Systematic Review and Meta-Analysis of 6458 Lesions.经皮诊断的单纯非典型性导管增生升级率:6458 例病灶的系统评价和荟萃分析。
Radiology. 2020 Jan;294(1):76-86. doi: 10.1148/radiol.2019190748. Epub 2019 Oct 29.